Babcock University Medical Journal · Published 2026-06-30 · DOI 10.38029/babcockuniv.med.j..v9i2.1211
Helyah Mohammed, Basim Ibrahim
Objective: To evaluate the influence of hepatitis C virus (HCV) infection on serum interleukin-1 (IL-1) and high-sensitivity C-reactive protein (hs-CRP) levels among patients with chronic kidney disease (CKD). Methods: A cross-sectional study was conducted on 100 CKD patients (aged 40–69 years) attending Baghdad Teaching Hospital, Iraq, between November 2024 and February 2025. Participants were categorised into two groups: Group I (CKD without HCV infection, n=50) and Group II (CKD with HCV infection, n=50). Serum IL-1 and hs-CRP levels were measured using ELISA. Statistical analysis was performed using SPSS version 25.0. Group comparisons were made using Student’s t-test or Mann–Whitney test as appropriate, and ROC analysis was used to discriminate CKD+HCV from CKD–HCV patients. Results: IL-1 and hs-CRP levels were significantly higher in CKD+HCV patients than in CKD–HCV patients (p < 0.001). hs-CRP suggests excellent discriminatory ability (AUC = 0.976, sensitivity = 100%, specificity = 96%), while IL-1 showed moderate performance (AUC = 0.675). Conclusion: hs-CRP is a more reliable biomarker than IL-1 for identifying inflammation associated with HCV infection in CKD patients, supporting its potential role in cardiovascular risk stratification and monitoring.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Mohammed, H., Ibrahim, B. (2026). Serum levels of C-reactive protein and interleukin-1 among patients with chronic kidney disease and the influence of hepatitis C virus infection. Babcock University Medical Journal. https://doi.org/10.38029/babcockuniv.med.j..v9i2.1211